The role of melatonin in preventing radiation-induced intestinal injury
dc.contributor.author | Sezen, Orhan | |
dc.contributor.author | Erdemci, Burak | |
dc.contributor.author | Calik, Muhammet | |
dc.contributor.author | Koc, Mehmet | |
dc.date.accessioned | 2024-02-23T14:49:26Z | |
dc.date.available | 2024-02-23T14:49:26Z | |
dc.date.issued | 2021 | |
dc.department | NEÜ | en_US |
dc.description.abstract | Purpose: Despite the therapeutic effects of radiotherapy on tumor cells, it has potential severe adverse effects on the sur- rounding normal tissues. Acute or chronic intestinal adverse effects that are likely to occur in patients undergoing radio- therapy for pelvic and abdominal cancers lead to increased morbidity, significant impairment of the quality of life, and economic losses. Various biological, chemical and pharma- cological agents are being tested to protect from and to treat radiation enteritis. This experimental study aimed to inves- tigate the protective effects of melatonin against radiation induced intestinal injury when administered before radiation exposure in rats. Methods: In the present study, villus height and the number of villi in the ileum and jejunum of rats receiving two dif- ferent doses of intraperitoneal melatonin (5 and 10 mg/kg) prior to a single fraction of radiation given at a dose of 8 Gy to the abdominal region, was evaluated by histopathological examination 3 and 7 days after radiation exposure. Results: At a dose of 5 mg/kg, melatonin was found to be effective in preventing radiation-induced injury to villus height in the jejunum and the number of villi in the ileum and jejunum, and at a dose of 10 mg/kg it was also effective in preventing radiation-induced injury to villus height in the ileum. Conclusions: Melatonin is effective for the prevention of radiation-induced intestinal injury. This outcome can be considered an evidence to test melatonin in clinical trials. | en_US |
dc.identifier.endpage | 633 | en_US |
dc.identifier.issn | 1107-0625 | |
dc.identifier.issn | 2241-6293 | |
dc.identifier.issue | 2 | en_US |
dc.identifier.pmid | 34077015 | en_US |
dc.identifier.scopus | 2-s2.0-85105405967 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 626 | en_US |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/18189 | |
dc.identifier.volume | 26 | en_US |
dc.identifier.wos | WOS:000646957600021 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Imprimatur Publications | en_US |
dc.relation.ispartof | Journal Of Buon | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Intestinal Injury | en_US |
dc.subject | Melatonin | en_US |
dc.subject | Radiation Enteritis | en_US |
dc.subject | Radioprotective | en_US |
dc.subject | Radiotherapy | en_US |
dc.title | The role of melatonin in preventing radiation-induced intestinal injury | en_US |
dc.type | Article | en_US |